ICD-10-CM Billable Code

C40.92

Malignant neoplasm of unspecified bones and articular cartilage of left limb

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code C40.92 refers to a malignant tumor, commonly known as cancer, that develops in the bones and cartilage of the left limb. This diagnosis involves an aggressive growth of abnormal cells, which can spread to adjacent tissues or other parts of the body if not treated promptly. The term 'unspecified' indicates that the exact bone or cartilage affected has not been detailed in this classification, emphasizing the importance of medical evaluation for precise diagnosis and treatment planning.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting cell growth and division Exposure to radiation or carcinogenic substances Previous history of cancer in the same or other areas Pre-existing bone or cartilage diseases that may increase risk Environmental factors that might contribute to cellular mutations

Key Symptoms: Persistent bone pain or tenderness in the affected limb Swelling or a palpable mass around the limb Weakness or limited movement in the limb Unexplained weight loss and fatigue Fractures occurring with minimal trauma due to weakened bones Loss of function or mobility in the affected limb

Diagnostic & Treatment

Diagnosis Path: Imaging tests such as X-rays, MRI, or CT scans to visualize the tumor Biopsy procedures to obtain tissue samples for histologic examination Bone scans to identify the extent and spread of the neoplasm Laboratory tests to assess overall health and detect tumor markers Assessment of the tumor's genetic and molecular characteristics for targeted therapy options

Treatment Protocols: Surgical removal of the tumor, which may involve limb-sparing procedures or amputation in advanced cases Radiation therapy aimed at reducing tumor size or eliminating residual cancerous cells Chemotherapy to target cancer cells systemically, especially if metastasis is suspected Targeted therapy based on specific genetic mutations in the tumor Rehabilitation services to restore function and mobility post-treatment Supportive care to manage pain and improve quality of life

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C40.92 a billable ICD-10 code?
Yes, C40.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C40.92?
Clinical documentation must specify the nature of Malignant neoplasm of unspecified bones and articular cartilage of left limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

bones neoplasm articular malignant cartilage